Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-27

Clinical Trial Update: Intramuscular Phenylephrine HCL for Prevention of Spinal Anesthesia Induced Hypotension [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating intramuscular phenylephrine HCL to prevent spinal anesthesia-induced hypotension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Phenylephrine HCl (phenylephrine)

Snippet

Sponsor: Rehman Medical Institute - RMI | Conditions: Hypotension, Anesthesia | Phase 4 | Status: COMPLETED